Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance With Age; the Role of Amino Acids in Modulating Muscle Metabolism

NCT ID: NCT01735539

Last Updated: 2014-01-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators plan to measure changes in muscle protein metabolism in response to feeding, comparing between a single large essential amino acid (EAA) feed (the normal building blocks of protein) and the provision of the same dose in 4 smaller feeds at 45min intervals. The investigators will perform this study in healthy older (65-75y) and younger (18-28) men. The investigators will also explore how feeding affects muscle blood flow as this is important in the delivery of the nutrients we eat to the muscle where they are used.

The investigators plan to supplement the feed with arginine, a safe and widely found non-essential amino acid, to explore if this can improve muscle blood flow.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will provide a 15g mixed essential amino acid feed or 4 x 3.75g.

There is sexual dimorphism thus initially we will just recruit males. Powering calculations dictate n=8 in each group.

We will use well established stable isotope tracer techniques (with 13C6 Phenylalanine) to measure muscle protein synthesis and breakdown by Gas Chromatography - combustion - isotope ratio mass spectroscopy.

We will measure leg blood flow by phase shift Doppler and muscle microvascular flow by contrast enhanced ultrasound.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Old Age (Focus; Not a Recognized Condition)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Old Bolus

15g EAA bolus

Group Type EXPERIMENTAL

15g EAA bolus

Intervention Type DIETARY_SUPPLEMENT

Oral; in aqueous solution

Old Arginine

15g EAA Bolus supplemented with 3g Arginine

Group Type EXPERIMENTAL

15g EAA Bolus supplemented with 3g Arginine

Intervention Type DIETARY_SUPPLEMENT

Oral; in aqueous solution

Young Bolus

15g EAA bolus

Group Type EXPERIMENTAL

15g EAA bolus

Intervention Type DIETARY_SUPPLEMENT

Oral; in aqueous solution

Young Pulse

4 x 3.75g Mixed EAA Pulses

Group Type EXPERIMENTAL

4 x 3.75g Mixed EAA Pulses

Intervention Type DIETARY_SUPPLEMENT

Oral; in aqueous solution

Old Pulse

4 x 3.75g Mixed EAA Pulses

Group Type EXPERIMENTAL

4 x 3.75g Mixed EAA Pulses

Intervention Type DIETARY_SUPPLEMENT

Oral; in aqueous solution

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

15g EAA bolus

Oral; in aqueous solution

Intervention Type DIETARY_SUPPLEMENT

4 x 3.75g Mixed EAA Pulses

Oral; in aqueous solution

Intervention Type DIETARY_SUPPLEMENT

15g EAA Bolus supplemented with 3g Arginine

Oral; in aqueous solution

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mixed Essential Amino Acids

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 65-75 or 18-28

Exclusion Criteria

* BMI \>30
* Diabetes
* Beta blocker or steroid use
* Established cerebrovascular, peripheral vascular or ischaemic heart disease.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nottingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philip J Atherton, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Nottingham

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Nottingham School of Graduate Entry Medicine and Health

Derby, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Mitchell WK, Phillips BE, Williams JP, Rankin D, Lund JN, Smith K, Atherton PJ. A dose- rather than delivery profile-dependent mechanism regulates the "muscle-full" effect in response to oral essential amino acid intake in young men. J Nutr. 2015 Feb;145(2):207-14. doi: 10.3945/jn.114.199604. Epub 2014 Dec 10.

Reference Type DERIVED
PMID: 25644339 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UNottingham F/3/2009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Protein Supply in Elderly
NCT01317511 COMPLETED NA